Based on its cash, cash equivalents and investments as of December 31, the company continues to expect its cash runway to fund operations into ...

Analysts at HC Wainwright issued their FY2024 earnings per share (EPS) estimates for shares of BioNTech in a research report ...

After the boycott’s launch Friday, March 7, Amazon stock underwent a transient 2.12 percent dip, with shares dropping from an ...

The EC’s committee on expatriate voting rights has suggested a roadmap, which the commission approved yesterday.

Viking Therapeutics eyes billion-dollar obesity drug markets with pivotal trials and major production deals. Read more about ...

Officers, 10% owners, and other insiders have shelled out more than $10 million on each of these four biotech stocks in the ...

Shares of Nektar Therapeutics (NASDAQ:NKTR – Get Free Report) have earned a consensus rating of “Buy” from the six analysts ...

Even after South Korea’s Constitution Court delivers its verdict, the country’s fierce and fractured partisan divide is ...

Corrections often lead to robust recoveries, with historical returns averaging 25% in the year following severe volatility.

SportsLine's computer model revealed its best bets for Bradley Braves vs. Drake Bulldogs at the 2025 Missouri Valley ...

Novo Nordisk on Monday revealed data from a second late-stage trial of its obesity drug candidate CagriSema, knocking shares ...

During a Case-Based Roundtable® event, Robert Z. Orlowski, MD, PhD, discussed the case of a patient who had progression of ...